NY Congressman Condemns FDA Ruling on
Medical Marijuana
by Jeff Lieberson for Maurice Hinchey (D-NY)
(27 Apr, 2006)Hinchey leads bipartisan House
coalition in calling for FDA to explain baseless
anti-medical marijuana policy
Medical Marijuana
by Jeff Lieberson for Maurice Hinchey (D-NY)
(27 Apr, 2006)Hinchey leads bipartisan House
coalition in calling for FDA to explain baseless
anti-medical marijuana policy
Washington, DC -- One week after the Food and Drug Administration
(FDA) issued a baseless, one page press release claiming that marijuana
had no medical benefits,
(FDA) issued a baseless, one page press release claiming that marijuana
had no medical benefits,
Congressman Maurice Hinchey (D-NY) led a bipartisan group of 24
House members in calling on the agency to explain its reasoning and
show scientific proof to support its view.
Hinchey, who has offered an amendment in the House three times that
would bar the federal government from prosecuting medical marijuana
patients, doctors, and suppliers in states where medical marijuana is
legal, and his colleagues said the FDAÂ’s action appears to be politically
motivated and defies the results of a White House-commissioned
Institute of Medicine (IOM) study from 1999 that detailed the benefits of
medical marijuana use.
WAIT !
THERE"S
MORE !!
LISTEN TO
THIS
Check bottom of page
THERE"S
MORE !!
LISTEN TO
THIS
Check bottom of page
| Congressman Maurice Hinchey (D-NY) |
“Despite the fact that you are responding to a scientific question, your press release failed to provide any scientific
expertise. We call on you to show us the purported scientific evidence for the basis of this response. There is no evidence
that you have new scientific proof or that you oversaw clinical trials,” Hinchey and his colleagues wrote in a letter sent today
to FDA Acting Commissioner Andrew von Eschenbach. “It perplexes us that even though the FDA is responsible for
protecting public health, the agency has failed to respond adequately to the IOMÂ’s findings seven years after the studyÂ’s
publication date.”
On April 20, the FDA issued a one-page press release without any documentation to back up its claim that, “...No sound
scientific studies supported medical use of marijuana for treatment in the United States, and no animal or human data
supported the safety or efficacy of marijuana for general medical use.” This statement fails to take into account the IOM
report from 1999, which found that marijuanaÂ’s active components are potentially effective in treating pain, nausea, the
anorexia of AIDS wasting, and other symptoms, and should be tested rigorously in clinical trials.
“We saw it with the agency’s decision on the emergency contraceptive, Plan B, and we’re seeing it again with medical
marijuana: the FDA is making decisions based on politics instead of science,” Hinchey said. “The FDA should not be a
political entity. Rather, the agency should be in the business of ensuring all Americans have access to safe and effective
drugs, including medical marijuana.”
Hinchey and his colleagues noted in their letter to von Eschenbach that the FDA has an Investigational New Drug (IND)
Compassionate Access Program, which allowed some Americans with certain medical conditions to apply to the agency
to receive marijuana from the federal government. Seven people are currently still in the program and routinely receive
marijuana from the federal government. The House members suggest that the IND is an example of how the FDA could
allow for the legal use of marijuana without having to go through the series of steps many other drugs go through before
getting approved.
WAIT ! THERE"S MORE !!
LISTEN TO THIS
(may require plug in)
LISTEN TO THIS
(may require plug in)
Real Audio
Mother Nature
Doesn't Make
Mistakes
Doesn't Make
Mistakes
Media Player
Quick Time
Dr. Julian Whitaker talks about what he believes are abuses by pharmaceutical companies and
the FDA, as well as alternative treatments for life threatening illnesses.
the FDA, as well as alternative treatments for life threatening illnesses.
 |  |  |  |  |  |
HEMP
